This week, the healthcare technology sector witnessed a significant legal confrontation when New York City-based startup Particle Health filed an antitrust lawsuit against Epic Systems. The complaint, submitted in the Southern District of New York, accuses the EHR giant of utilizing its market dominance to stifle competition, particularly in the payer platform space.
Particle’s lawsuit asserts that Epic has deliberately impeded the startup’s ability to compete by blocking Particle customers from accessing critical healthcare data. This maneuver, according to Particle, places it at a severe disadvantage in an emerging market for digital platforms, where the goal is to enable payers to access and analyze patient data to improve care coordination, streamline claims processing, and design population health programs.
Founded in 2018, Particle Health has built its business model around facilitating access to patient data held by EHR systems, acting as an intermediary via API connections. The startup also participates in nationwide health data exchanges, such as Carequality and CommonWell. Their entry into the payer market came as health insurers started transforming into “payviders,” offering healthcare services directly to their members.
Epic, a dominant player in the EHR market, launched its payer platform in 2021, establishing contracts with the nation’s largest health plans. As Particle entered the market, it faced opposition, including a formal complaint Epic filed with Carequality, accusing Particle of violating HIPAA by allegedly sharing patient data with payers not involved in treatment. Epic subsequently cut off data access for Particle customers, citing potential HIPAA violations and security risks (MedCity News).
Particle, however, disputes these claims, arguing that all affected partners support treatment and were properly vetted by Carequality. Particle CEO Jason Prestinario criticized Epic’s actions through a public statement, emphasizing the harm caused to patients’ access to medical data and calling for more competition in the payer data platform market (Particle Health blog).
Industry experts argue that the feud highlights a broader issue of transparency within health data exchanges. Critics, including Brendan Keeler from Zus Health, argue for clearer guidelines on data usage and increased transparency about the purposes for which data is used. Health data remains critical for improving patient care, and the dispute serves as a backdrop to larger systemic issues related to data access and market competition.
The legal struggle between Particle and Epic underscores the evolving complexities and competitive dynamics in health information technology. Whether Particle’s lawsuit will proceed to trial remains uncertain, yet its outcome has the potential to shape the future of data access and competition within the industry.